Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Koninklijke Philips NV (PHG) vs Rambus Inc. Common Stock (RMBS) Price & Performance

Koninklijke Philips NVTrade
Rambus Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Koninklijke Philips NV vs Rambus Inc. Common Stock — how do they compare? Koninklijke Philips NV trades at $24.98 (market cap $24.24B), while Rambus Inc. Common Stock trades at $90.15 (market cap $10.66B). The key difference: Koninklijke Philips NV is far larger — about 2.3× Rambus Inc. Common Stock's market cap, and Koninklijke Philips NV pays a 4.07% dividend while Rambus Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Rambus Inc. Common Stock for 0 Days on average.

PHGRMBS
Market Cap
$24.24B$10.66B
Volume
982,7662,136,075
Sector
HealthTechnology
52-Week High
$32.91$170.66
52-Week Low
$23.81$79.73
Typical Hold Time
84 Days0 Days
Enterprise Value
$30.57B$9.85B
Dividend Yield
4.07%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Koninklijke Philips NV

PHG trades at $25.00, up 1.05% today, with a bullish technical signal despite mixed oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.57 exceeding the $0.40 estimate. Revenue for 2025 was $17.83 billion, with a net income margin of 5.01%, showing a recovery from prior losses. Recent news highlights product launches and strategic partnerships in healthcare technology.

The outlook is cautiously optimistic, supported by earnings momentum and innovation, but risks include competitive pressures and debt levels. Analysts are mixed, with a 'Hold' consensus, while institutional buying activity indicates underlying confidence. Valuation metrics like a P/E of 19.49 suggest the stock is fairly priced relative to peers.

Rambus Inc. Common Stock

Rambus (RMBS) trades at $98.17, down 2.84% over 24 hours, with a neutral technical signal and key support at $96. The company reported strong profitability with a 31.69% net income margin and beat EPS estimates in two of the last three quarters. Recent news highlights its focus on AI infrastructure with new product launches, positioning it to benefit from growing demand for high-speed memory solutions.

The outlook is positive given analyst consensus of a $161.75 price target and 78.57% buy ratings, but risks include high valuation multiples and competitive pressures. Execution on AI-driven growth and maintaining earnings momentum are critical for stock appreciation, while any miss in upcoming results could pressure the premium valuation.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PHG

No sentiment data available yet.

RMBS
100% Buy0% Sell
Avg holding period · 0 Days

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG →

About Rambus Inc. Common Stock

Rambus Inc. is a semiconductor and silicon IP company that licenses chip interface and security technologies, including memory interface chipsets for DDR5 and DDR4 server and client DIMMs, interface IP for PCIe, CXL, and HBM, and security IP such as Root of Trust and memory encryption. It serves data center, AI, automotive, and IoT markets.

Read more on RMBS →